Volastra Therapeutics
Series ACancer therapies targeting chromosomal instability
Similar Startups
OpenEvidence
Organizing the world’s medical knowledge
Series D
Freenome
Blood test to detect colorectal cancer
Moderna
mRNA vaccines
Human Longevity
Early detection for longer life
Series B
Cleerly
Precision medicine for heart health
Series C
Kuehnle Agrosystems
Algae and botanical product ingredients
Series B
Volastra Therapeutics is a Cornell-founded startup based in New York, NY, founded by Lewis Cantley, PhD ’75 and Olivier Elemento, Professor.